Patrick Forde, MD
Trinity St James Cancer Institute, Dublin, Ireland · Johns Hopkins University · John Hopkins
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Patrick Forde, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:27 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT06931717 · A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed Non-small Cell Lung Cancer Who Have Not Received Prior ChemotherapyETOP IBCSG Partners Foundation · recruiting · Non-Small Cell Lung Cancer · study chair
- Ph3NCT04334759 · DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural MesotheliomaPrECOG, LLC. · completed · Mesothelioma, Pleural Mesothelioma, Malignant Pleural Mesothelioma · study chair
- Ph2NCT03237377 · Neoadjuvant Immunoradiation for Resectable Non-Small Cell Lung CancerSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · terminated · Non-Small Cell Lung Cancer · principal investigator
- Ph2NCT02899195 · Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable MesotheliomaPrECOG, LLC. · completed · Mesothelioma, Pleural Mesothelioma · study chair
- Ph2NCT02259621 · Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLCSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · active not recruiting · Non-Small Cell Lung Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:27 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.